Stent maker CardioMind raises $33M
CardioMind, a secretive Sunnyvale, Calif., developer of stents designed to prop open blocked arteries, raised $33 million in a third round of funding, VentureWire reports (subscription required). From the VentureWire story:
CardioMind, with 30 employees, is developing small-diameter drug-eluting stents and delivery devices for cardiovascular and neurological indications and has been largely operating in stealth mode for the past five years.
SV Life Sciences and De Novo Ventures led the round, joined by InterWest Partners, Latterell Venture… Continue Reading